The Mission on Cancer aims to deliver concrete outcomes such as new biomarkers for early detection, innovative therapeutic approaches, and improved survivorship care plans. By 2030, it seeks to significantly reduce the cancer burden in Europe, improving survival rates and quality of life for patients.
